Skip to content
Search
Search
Close this search box.
Search
Search
Subscribe
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Home
Sectors
Health Care
Materials
Consumer Staples
Utilities
Energy
Industrials
Financials
Information Technology
Consumer Discretionary
Communication Services
Real Estate
All Articles
Contact Us
Menu
Home
Sectors
Health Care
Materials
Consumer Staples
Utilities
Energy
Industrials
Financials
Information Technology
Consumer Discretionary
Communication Services
Real Estate
All Articles
Contact Us
Stock Piper AI Index
Subscribe
Search
Search
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
Hang Seng
17,093.50
(3.05%)
Dow Jones
39,023.71
(0.66%)
Nikkei 225
38,797.51
(-0.06%)
FTSE 100
7,747.81
(1.02%)
USD/AUD
0.6617
(-0.2%)
Bitcoin
71,640.19
(-1.56%)
Oil
78.00
(0.57%)
Gold
2,163.90
(-0.1%)
Lithium
46.11
(4.37%)
Iron Ore
109.15
(1.77%)
ASX:
RCE
Articles
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) reports positive data from phase I/II UTI/urosepsis rapid infusion clinical trial
June 28, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) receives ethics approval to centralise and broaden RECCE® 327 gel clinical trials
June 24, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) receives further R&D tax incentive rebate
June 18, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) secures WHO recognition for RECCE® 327
June 18, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) doses first participants in uti/urosepsis trial
May 15, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) approves high dose of 4,000mg for urinary tract infection/urosepsis trial
April 26, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) progresses clinical trials and secures USD $2.2M grant for R327G
April 8, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) granted patent for RECCE® anti-infectives in Israel
April 3, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) completes dosing for UTI/Urosepsis clinical trial
March 15, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) secures $11.17m R&D advance
March 8, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) demonstrates efficacy against neisseria gonorrhoeae
January 12, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) awarded advanced overseas finding for synthetic anti-viral development program
January 12, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX: $RCE) awarded overseas r&d finding for synthetic anti-infective development program
January 12, 2024
Health Care
$RCE
Recce Pharmaceuticals (ASX:$RCE) awarded advanced overseas finding for synthetic anti-viral development program
December 19, 2023
Health Care
$RCE
Recce Pharmaceuticals (ASX:$RCE) awarded overseas r&d finding for synthetic anti-infective development program
December 14, 2023
Health Care
$RCE
Recce Pharmaceuticals (ASX:$RCE) demonstrates efficacy against neisseria gonorrhoeae
December 14, 2023
Home
Industry Sectors
All Articles
Contact Us
Join FREE Newsletter
ASX News, First And Fast.
Get all the latest market updates straight to your inbox.
Your Email
Investor type
Retail Investor
708 Investor
Institutional Investor
Media
Analyst
Corporate
Tick box to receive Stock Piper Marketing content
Subscribe
By clicking Subscribe, you agree to our
Terms & Conditions
Stock Piper AI Index Coming Soon!
Join our Newsletter to gain exclusive insight and be notified once we are live.
Your Email
Investor type
Retail Investor
708 Investor
Institutional Investor
Media
Analyst
Corporate
Tick box to receive Stock Piper Marketing content
Subscribe
By clicking Subscribe, you agree to our
Terms & Conditions